Istalol and Ocular hyperaemia - a phase IV clinical study of FDA data

Summary:

Ocular hyperaemia is reported as a side effect among people who take Istalol (timolol maleate), especially for people who are female, 60+ old, also take Combigan, and have Dry eyes.

The phase IV clinical study analyzes which people have Ocular hyperaemia when taking Istalol. It is created by eHealthMe based on reports of 294 people who have side effects when taking Istalol from the FDA, and is updated regularly.

What is Istalol?

Istalol has active ingredients of timolol maleate. It is often used in glaucoma. eHealthMe is studying from 309 Istalol users. Check the latest studies of Istalol.

What is Ocular hyperaemia?

Ocular hyperaemia (an abnormally large amount of blood in eye) is found to be associated with 1,354 drugs and 1,500 conditions by eHealthMe. Check the latest studies of Ocular hyperaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

294 people reported to have side effects when taking Istalol.
Among them, 11 people (3.74%) have Ocular hyperaemia.

Among these 11 people:

What is the gender of people who have Ocular hyperaemia when taking Istalol? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Ocular hyperaemia when taking Istalol? *

What are other drugs people take besides Istalol? *

What are other side effects people have besides Ocular hyperaemia? *

Eye Irritation: 5 people, 45.45%
Eye Pain: 4 people, 36.36%
Vision Blurred: 3 people, 27.27%
Speech Disorder: 1 person, 9.09%
Abnormal Sensation In Eye: 1 person, 9.09%
Dark Circles Under Eyes: 1 person, 9.09%
Drug Ineffective: 1 person, 9.09%
Dry Skin: 1 person, 9.09%
Dyspnea (difficult or laboured breathing): 1 person, 9.09%
Eye Pruritus (eye itching): 1 person, 9.09%

What are the existing conditions these people have? *

Dry Eyes (lack of adequate tears): 3 people, 27.27%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 18.18%
Eye Pruritus (eye itching): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Istalol and have Ocular hyperaemia?

- Check whether Ocular hyperaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Istalol:

Istalol (309 reports)

Browse all side effects of Istalol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,354 drugs)

Browse all the conditions that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on timolol maleate (the active ingredients of Istalol) and Istalol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.